New MS diagnostic criteria put to the test in Real-World study

NCT ID NCT07492667

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares the 2024 and 2017 McDonald criteria for diagnosing multiple sclerosis (MS) in 100 patients with symptoms suggestive of MS. Researchers will see if the newer criteria catch more cases early without extra tests. The goal is to improve diagnosis and guide future updates.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors diagnose multiple sclerosis earlier and more accurately using the latest criteria.
What could go wrong
This is an observational study, not a treatment trial. It may not change practice if the new criteria don't prove clearly better in real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EVENT SUGGESTIVE OF MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Hospitalier Régional Universitaire

    RECRUITING

    Nancy, Lorraine, F-54000, France

  • Centre Hospitalier Régional de Metz, site Mercy

    RECRUITING

    Ars-Laquenexy, Lorraine, F-57530, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.